Page 2 - Burnet Institute

Medications

Updated treatment guidelines for drug-resistant TB

New World Health Organization (WHO) guidelines for the treatment of drug resistant tuberculosis (DR-TB) are shaping as a game changer for the estimated 500,000 people diagnosed with DR-TB each year, and the longer-term goal ...

Diseases, Conditions, Syndromes

A two-pronged approach to target critical malaria protein

A protein that plays a critical role in helping malaria parasites infect red blood cells—known as apical membrane protein 1 (AMA1)—has been found to bind to more than one receptor on the surface of the cells.

Medications

New insights into medicines for preeclampsia

Burnet Institute researchers have led the development of the first global strategic guidelines—called target product profiles (TPPs)—for medicines to prevent and treat preeclampsia, a hypertensive disorder in pregnancy ...

page 2 from 5